QDEL News Alert Quidel Corp (QDEL) 25.18 02/13/2015 23:18:45

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 12:18 AM

Quidel Corp (QDEL) 25.18 $QDEL

Quidel's (QDEL) CEO Douglas Bryant on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 11, 8:55PM CST

QDEL: 25.18 (+0.35)

Quidel beats 4Q profit forecasts
Automated Insights - Wed Feb 11, 6:27PM CST
SAN DIEGO (AP) _ Quidel Corp. (QDEL) on Wednesday reported fourth-quarter profit of $7.1 million.
QDEL: 25.18 (+0.35)

Quidel (QDEL) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Feb 11, 3:55PM CST

QDEL: 25.18 (+0.35)

Quidel beats by $0.28, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 3:21PM CST

QDEL: 25.18 (+0.35)

Quidel Reports Fourth Quarter and Full Year 2014 Financial Results
Marketwired - Wed Feb 11, 3:10PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the fourth quarter and year ended December 31, 2014.
QDEL: 25.18 (+0.35)

Should You Buy Quidel (QDEL) Ahead of Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 7:46AM CST
Quidel has a favorable Zacks Rank and an ESP in positive territory, thus investors might want to consider this stock ahead of earnings
QDEL: 25.18 (+0.35)

Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 4:35PM CST

TSLA: 203.77 (+0.89), ITRI: 35.75 (-0.12), PNRA: 155.02 (-2.31), SKX: 66.09 (-0.06), STMP: 56.92 (-0.24), ZEN: 25.38 (+1.02), SLF: 31.31 (-0.09), FET: 18.70 (+2.61), HOS: 20.45 (+1.52), HIVE: 4.26 (+0.15), AEM: 32.61 (+0.10), CAKE: 48.22 (-1.04), AMAT: 24.12 (-0.02), CSCO: 29.43 (-0.03), WFM: 56.15 (-0.15), CJES: 12.98 (+1.36), HNI: 53.44 (+2.60), IO: 2.54 (+0.02), GAS: 50.07 (+0.27), QDEL: 25.18 (+0.35), CSOD: 35.03 (+2.02), EXL: 13.74 (-0.08), NVDA: 22.31 (+0.01), DDR: 19.41 (-0.28), NTWK: 5.14 (-0.11), AMBR: 8.37 (+0.13), CPA: 119.12 (+0.27), FORR: 37.58 (-0.03), AUY: 4.13 (+0.13), CTL: 39.46 (+0.17), ACHC: 63.20 (-0.45), OII: 50.47 (+0.59), NU: 51.02 (-1.28), CVA: 21.45 (+0.64), PPC: 26.75 (+0.77), REG: 66.77 (-0.46), TAL: 41.00 (+0.37), SWM: 43.15 (-0.86), Z: 106.50 (+1.75), FEYE: 42.26 (+2.63), ABCO: 53.69 (+0.32), TCX: 18.30 (-0.13), DIOD: 27.81 (-0.32), MET: 50.86 (+0.53), SPRT: 1.78 (+0.04), TRIP: 84.81 (+2.41), CYS: 8.78 (+0.04), NSIT: 25.92 (+1.31), TTGT: 11.90 (+0.60), NTAP: 38.22 (+1.32), EFX: 92.56 (-0.18), CRAY: 32.65 (+0.24), LPSN: 10.74 (+0.38), BIDU: 212.13 (+7.11), TSO: 81.92 (+0.50), CXW: 39.92 (+0.72), SCSS: 32.14 (+0.43), EFC: 20.75 (-0.01)

Quidel Down 10.5% Since SmarTrend Downtrend Call (QDEL)
Comtex SmarTrend(R) - Tue Feb 10, 9:19AM CST
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on January 15th, 2015 at $25.49. In approximately 4 weeks, Quidel has returned 10.50% as of today's recent price of $22.81.
QDEL: 25.18 (+0.35)

Quidel reports February 11
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 9:12PM CST

QDEL: 25.18 (+0.35)

Quidel to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on February 11, 2015
Marketwired - Wed Jan 28, 5:30PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will release fourth quarter and full year 2014 financial results after market close on Wednesday, February 11, 2015.
QDEL: 25.18 (+0.35)

Quidel to Present at 33rd Annual J.P. Morgan Healthcare Conference
Marketwired - Mon Jan 05, 3:05PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the 33rd Annual J.P. Morgan Healthcare Conference to be held at The Westin St. Francis hotel in San Francisco, California on Wednesday, January 14, 2015.
JPM: 59.67 (+0.10), QDEL: 25.18 (+0.35)

Quidel Receives Simultaneous FDA Clearance and CLIA Waiver for Its Sofia(R) Strep A+ Fluorescent Immunoassay (FIA) via the FDA's New Dual Submission Program
Marketwired - Wed Dec 17, 5:45PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it has received marketing clearance and CLIA waiver by the United States Food and Drug Administration (FDA) for its Sofia Strep A+ Fluorescent Immunoassay (FIA) for the rapid detection of infections by Group A Streptococcus bacteria. These bacteria are the most common cause of bacterial pharyngitis and can also cause rheumatic fever and other potentially serious illnesses.
QDEL: 25.18 (+0.35)

Quidel wins US FDA clearance to market AmpliVue molecular diagnostic test for Bordetella pertussis
M2 - Fri Dec 12, 7:01AM CST
Diagnostic testing company Quidel (NASDAQ:QDEL) revealed on Thursday the receipt of clearance from the US Food and Drug Administration (FDA) to market its AmpliVue Bordetella Assay for the detection of Bordetella pertussi.
QDEL: 25.18 (+0.35)

Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Bordetella Pertussis
Marketwired - Wed Dec 10, 3:30PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received clearance from the United States Food and Drug Administration (FDA) to market its AmpliVue Bordetella Assay for the detection of Bordetella pertussis nucleic acids isolated from nasopharyngeal swab specimens obtained from patients suspected of having a respiratory tract infection attributable to Bordetella pertussis.
QDEL: 25.18 (+0.35)

Quidel prices debt offering
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 7:23AM CST

QDEL: 25.18 (+0.35)

Quidel Announces Pricing of $150 Million Convertible Senior Notes Offering
Marketwired - Tue Dec 02, 10:10PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announced the pricing of its previously announced underwritten public offering of $150 million aggregate principal amount of its 3.25% convertible senior notes due 2020 (the "notes"

. Quidel has granted the underwriters of the notes a 30-day option to purchase up to an additional $22.5 million aggregate principal amount of the notes, solely to cover over-allotments, if any. BofA Merrill Lynch and J.P. Morgan are acting as book-running managers for the proposed notes offering. The offering is expected to close on or around December 8, 2014, subject to satisfaction of customary closing conditions.
JPM: 59.67 (+0.10), QDEL: 25.18 (+0.35)

Nasdaq stocks posting largest volume increases
AP - Tue Dec 02, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
CY: 14.76 (+0.01), FBNK: 15.20 (+0.11), SHBI: 9.36 (-0.03), VGGL: 1.77 (-0.08), QDEL: 25.18 (+0.35), ISIG: 3.19 (unch), POZN: 6.95 (+0.15), PFBX: 10.35 (+0.27), IROQ: 16.70 (unch), ORPN: 7.17 (+0.04), OBAS: 6.25 (-0.05)

Nasdaq stocks posting largest percentage decreases
AP - Tue Dec 02, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
EVOK: 5.41 (-0.10), CTCM: 4.14 (+0.12), RDCM: 9.85 (-0.16), MCEP: 6.29 (+0.12), QDEL: 25.18 (+0.35), POZN: 6.95 (+0.15), AREX: 8.15 (+0.27)

Quidel off on convertible debt offering
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 12:46PM CST

QDEL: 25.18 (+0.35)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Ruth E. Carter Returns Home with Celebrated Exhibition

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Venue Two Eleven: Historic Charm Meets Modern Events

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Alaska LNG Project Boosted by Strategic Positioning

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

U.S. Millionaire Surge: Market Waves or Mirage?

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Costa Rican Firms Chase Growth at SIAL Paris 2026

Chasing Growth in Paris: Costa Rica's Bold Move When it comes to playing the global field, Costa Rica isn't just sitting back; they're on the move. Picture this: PROCOMER, along with 18 standout companies, landed smack dab in the grand hustle and bustle of SIAL Paris 2026. This isn't some leisurely stroll—it's a calculated sprint toward expanding their reach across...

Spooky Suds: House of Horror Meets El Car Wash

A Haunted Wash Awaits Miami Drivers Picture this: you're cruising down West Flagler on a regular Wednesday evening, but tonight, you're not just rolling in for a rinse. Nope, this Wednesday night, the wash tunnel at El Car Wash gets downright spooky. It's getting a haunted house makeover with scare actors from the House of Horror. When a Car Wash Becomes a Haunted...

Spire's Year-End Call: Eyes on Earnings & Guidance

Anticipation Builds for Spire's Upcoming Earnings Call If you're keen on natural gas and the energy sector, keep a firm grip on your coffee cup because Spire Inc. (NYSE: SR) is about to spill the beans on their fiscal 2026 financials. Mark your calendars for November 17. Whether you're tuning in via phone or hitching a ride on the webcast, you're in for an earful. Time...

Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...